Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $7.66 billion. The enterprise value is $7.29 billion.
| Market Cap | 7.66B |
| Enterprise Value | 7.29B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 135.38 million shares outstanding. The number of shares has increased by 13.05% in one year.
| Current Share Class | 112.95M |
| Shares Outstanding | 135.38M |
| Shares Change (YoY) | +13.05% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 17.04% |
| Owned by Institutions (%) | 82.73% |
| Float | 112.05M |
Valuation Ratios
The trailing PE ratio is 42.37 and the forward PE ratio is 17.22. Globus Medical's PEG ratio is 1.60.
| PE Ratio | 42.37 |
| Forward PE | 17.22 |
| PS Ratio | 3.07 |
| Forward PS | 2.52 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 4.07 |
| P/FCF Ratio | 14.66 |
| P/OCF Ratio | 11.87 |
| PEG Ratio | 1.60 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.12, with an EV/FCF ratio of 13.96.
| EV / Earnings | 39.31 |
| EV / Sales | 2.91 |
| EV / EBITDA | 10.12 |
| EV / EBIT | 16.00 |
| EV / FCF | 13.96 |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.45 |
| Quick Ratio | 2.60 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.18 |
| Interest Coverage | 198.65 |
Financial Efficiency
Return on equity (ROE) is 4.63% and return on invested capital (ROIC) is 6.60%.
| Return on Equity (ROE) | 4.63% |
| Return on Assets (ROA) | 5.90% |
| Return on Invested Capital (ROIC) | 6.60% |
| Return on Capital Employed (ROCE) | 10.54% |
| Revenue Per Employee | $473,738 |
| Profits Per Employee | $35,012 |
| Employee Count | 5,300 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.12 |
Taxes
In the past 12 months, Globus Medical has paid $47.39 million in taxes.
| Income Tax | 47.39M |
| Effective Tax Rate | 20.34% |
Stock Price Statistics
The stock price has decreased by -17.68% in the last 52 weeks. The beta is 1.20, so Globus Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | -17.68% |
| 50-Day Moving Average | 61.59 |
| 200-Day Moving Average | 74.70 |
| Relative Strength Index (RSI) | 37.94 |
| Average Volume (20 Days) | 1,382,647 |
Short Selling Information
The latest short interest is 4.64 million, so 3.43% of the outstanding shares have been sold short.
| Short Interest | 4.64M |
| Short Previous Month | 4.51M |
| Short % of Shares Out | 3.43% |
| Short % of Float | 4.14% |
| Short Ratio (days to cover) | 3.25 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.51 billion and earned $185.56 million in profits. Earnings per share was $1.34.
| Revenue | 2.51B |
| Gross Profit | 1.68B |
| Operating Income | 455.91M |
| Pretax Income | 66.55M |
| Net Income | 185.56M |
| EBITDA | 720.68M |
| EBIT | 455.91M |
| Earnings Per Share (EPS) | $1.34 |
Balance Sheet
The company has $461.27 million in cash and $92.79 million in debt, giving a net cash position of $368.48 million or $2.72 per share.
| Cash & Cash Equivalents | 461.27M |
| Total Debt | 92.79M |
| Net Cash | 368.48M |
| Net Cash Per Share | $2.72 |
| Equity (Book Value) | 4.09B |
| Book Value Per Share | 30.20 |
| Working Capital | 1.33B |
Cash Flow
In the last 12 months, operating cash flow was $645.55 million and capital expenditures -$122.96 million, giving a free cash flow of $522.59 million.
| Operating Cash Flow | 645.55M |
| Capital Expenditures | -122.96M |
| Free Cash Flow | 522.59M |
| FCF Per Share | $3.86 |
Margins
Gross margin is 67.05%, with operating and profit margins of 18.16% and 7.39%.
| Gross Margin | 67.05% |
| Operating Margin | 18.16% |
| Pretax Margin | 9.28% |
| Profit Margin | 7.39% |
| EBITDA Margin | 28.70% |
| EBIT Margin | 18.16% |
| FCF Margin | 20.81% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.05% |
| Shareholder Yield | -13.05% |
| Earnings Yield | 2.42% |
| FCF Yield | 6.82% |
Analyst Forecast
The average price target for Globus Medical is $94.30, which is 66.61% higher than the current price. The consensus rating is "Buy".
| Price Target | $94.30 |
| Price Target Difference | 66.61% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 9.77% |
| EPS Growth Forecast (5Y) | 59.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 11.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.03 |
| Piotroski F-Score | 5 |